Show simple item record

dc.contributorHamkar, R.EN
dc.contributorJalilvand, S.EN
dc.contributorAbdol Baghi, M.H.EN
dc.contributorJelyani, K.N.EN
dc.contributorEsteghamati, A.EN
dc.contributorHagh goo, A.EN
dc.contributorMohktari Azad, T.EN
dc.contributorNategh, R.EN
dc.date.accessioned2014-06-17T08:38:01Z
dc.date.available2014-06-17T08:38:01Z
dc.date.issued2009EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/1501/15_1_2009_0094_0103.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/117612
dc.description94-103EN
dc.description.abstractDuring the mass measles/rubella vaccination campaign in 2003 in Iran, many pregnant women were vaccinated mistakenly or became pregnant within 1 month of vaccination. To distinguish pregnant women who were affected by rubella vaccine as primary infection from those who had rubella reinfection from the vaccine, serum samples were collected 1-3 months after the campaign from 812 pregnant women. IgG avidity assay showed that 0.3% of the women had no rubella-specific IgG response; 14.4% had low-avidity anti-rubella IgG and were therefore not immune to rubella before vaccination; 85.3% had high-avidity antirubella IgG and were regarded as cases of reinfectionEN
dc.language.isoenEN
dc.subjectImmunoglobulin GEN
dc.subjectImmunoglobulin GEN
dc.subjectPregnancyEN
dc.subjectRubellaEN
dc.subjectAntibody AffinityEN
dc.subject.meshRubella VaccineEN
dc.titleDistinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant womenEN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 15 (‎1)‎, 94-103, 2009


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record